BCHE and ischemia: The non-selective cholinesterase inhibitor rivastigmine (formerly known as ENA-713), which increases ACh in the synaptic cleft and facilitates cholinergic transmission, reduced ischemia-mediated pyramidal cell loss in the hippocampal CA1 region (Tanaka et al., 1994).